Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients

Area of Science:

• Biochemistry
• Metabolic disorders
• Genetics

Background:

• 5-Amino-4-imidazolecarboxamide riboside 5 omino'-monophosphate (ZMP) is a key intermediate in purine biosynthesis.
• ZMP can be metabolized to inosine 5 omino'-monophosphate, degraded to Z-riboside, or phosphorylated to ZTP.
• ZTP accumulation in microbes is linked to folate depletion and may regulate cellular metabolism.

Purpose of the Study:

• To investigate the presence and significance of Z-nucleotides in human erythrocytes, particularly in individuals with Lesch-Nyhan syndrome.
• To explore the potential role of Z-nucleotide accumulation in the pathogenesis of purine overproduction disorders.

Main Methods:

• Analysis of Z-nucleotide levels in erythrocytes from patients with Lesch-Nyhan syndrome, partial HGPRT deficiency, and other purine overproduction disorders.
• Measurement of erythrocyte folate and guanosine triphosphate (GTP) levels.
• Comparison with normal controls and patients on allopurinol therapy.

Main Results:

• Z-nucleotides were detected in erythrocytes of five Lesch-Nyhan syndrome patients, with normal folate levels but reduced GTP levels.
• A small amount of Z-nucleotide accumulation was observed in one patient with partial HGPRT deficiency and two with other purine overproduction disorders.
• No Z-nucleotides were detected in 13 normal controls or three hyperuricemic patients on allopurinol.

Conclusions:

• Z-nucleotide formation in erythrocytes may indicate markedly increased rates of de novo purine biosynthesis.
• These findings suggest that metabolites of purine intermediates, such as Z-nucleotides, could play a role in the pathogenesis of Lesch-Nyhan syndrome.
• Further research is warranted to elucidate the precise mechanisms and implications of Z-nucleotide accumulation in these disorders.